Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.32 is 14% above its 5-year average of 5.54, around the middle of its 5-year range (3.28–10.82).
As of the fiscal period ended Tuesday, June 30, 2026. 15.29% below its 12-month average of 7.46.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.32.
CURRENT RATIO
6.32
CURRENT RATIO AVG TTM
7.46
CURRENT RATIO AVG 3Y
5.80
CURRENT RATIO AVG 5Y
5.54
CURRENT RATIO AVG 10Y
5.58
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.29%
CURRENT VS 3Y AVG
+8.83%
CURRENT VS 5Y AVG
+14.01%
CURRENT VS 10Y AVG
+13.22%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+67.98%
vs the sector median at left
Market Cap
$1.89B
Current Ratio
10.22
TTM Avg
11.68
3Y Avg
12.23
5Y Avg
12.24
Market Cap
$1.87B
Current Ratio
37.28
TTM Avg
15.04
3Y Avg
13.56
5Y Avg
10.93
Market Cap
$1.92B
Current Ratio
3.84
TTM Avg
3.30
3Y Avg
3.38
5Y Avg
3.69
Market Cap
$1.94B
Current Ratio
34.46
TTM Avg
28.89
3Y Avg
23.88
5Y Avg
16.33
Market Cap
$1.84B
Current Ratio
21.18
TTM Avg
6.27
3Y Avg
4.65
5Y Avg
4.09
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zymeworks Inc. (ZYME) | $1.89B | 6.32 | 7.46 | 5.80 | 5.54 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 9.69 | 5.24 | 4.11 | 4.46 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | 10.22 | 11.68 | 12.23 | 12.24 |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | 37.28 | 15.04 | 13.56 | 10.93 |
| Novavax, Inc. (NVAX)vs › | $1.86B | 2.33 | 1.55 | 1.13 | 1.26 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | 3.84 | 3.30 | 3.38 | 3.69 |
| Immunome, Inc. (IMNM)vs › | $1.85B | 15.08 | 9.38 | 7.12 | 8.07 |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.94B | 34.46 | 28.89 | 23.88 | 16.33 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 21.18 | 6.27 | 4.65 | 4.09 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.23 | 1.57 | 2.04 | 2.44 |
Current Ratio
6.32
Quick Ratio
6.32
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.32 |
| 2026-03-31 | 10.82 |
| 2025-12-31 | 5.52 |
| 2025-09-30 | 6.94 |
| 2025-06-30 | 7.69 |
| 2025-03-31 | 4.71 |
| 2024-12-31 | 3.40 |
| 2024-09-30 | 4.10 |
| 2024-06-30 | 7.01 |
| 2024-03-31 | 6.92 |
| 2023-12-31 | 7.41 |
| 2023-09-30 | 5.14 |
| 2023-06-30 | 4.49 |
| 2023-03-31 | 6.33 |
| 2022-12-31 | 5.70 |
| 2022-09-30 | 3.30 |
| 2022-06-30 | 3.28 |
| 2022-03-31 | 4.05 |
| 2021-12-31 | 4.01 |
| 2021-09-30 | 4.46 |
| 2021-06-30 | 4.73 |
| 2021-03-31 | 6.16 |
| 2020-12-31 | 5.31 |
| 2020-09-30 | 5.03 |
| 2020-06-30 | 6.48 |
| 2020-03-31 | 6.92 |
| 2019-12-31 | 3.78 |
| 2019-09-30 | 6.81 |
| 2019-06-30 | 9.07 |
| 2019-03-31 | 6.76 |
| 2018-12-31 | 6.82 |
| 2018-09-30 | 6.42 |
| 2018-06-30 | 7.25 |
| 2018-03-31 | 4.09 |
| 2017-12-31 | 6.30 |
| 2017-09-30 | 4.57 |
| 2017-06-30 | 5.59 |
| 2017-03-31 | 1.57 |
| 2016-12-31 | 2.81 |
| 2016-09-30 | 5.06 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 3.64 |
